Financial reports
ARS
2023 FY
Annual report to shareholders
7 Mar 24
10-K
2023 FY
Annual report
1 Mar 24
NT 10-K
Notice of late annual filing
1 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
29 Mar 24
8-K/A
Regulation FD Disclosure
28 Mar 24
8-K
Entry into a Material Definitive Agreement
28 Mar 24
8-K
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
27 Feb 24
8-K
Departure of Directors or Certain Officers
9 Feb 24
8-K
Other Events
24 Jan 24
8-K
Entry into a Material Definitive Agreement
9 Jan 24
8-K
OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
5 Jan 24
8-K
Regulation FD Disclosure
3 Jan 24
8-K
OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
6 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
15 May 23
424B5
Prospectus supplement for primary offering
25 Oct 19
424B5
Prospectus supplement for primary offering
24 Oct 19
424B5
Prospectus supplement for primary offering
22 Oct 19
424B2
Prospectus for primary offering
6 Feb 19
424B7
Prospectus with selling stockholder info
5 Feb 19
FWP
Free writing prospectus
5 Feb 19
424B5
Prospectus supplement for primary offering
4 Feb 19
S-3ASR
Automatic shelf registration
28 Jan 19
25
Voluntary exchange delisting
23 Jun 16
Proxies
DEF 14A
Definitive proxy
29 Feb 24
PRE 14A
Preliminary proxy
16 Feb 24
DEFA14A
Additional proxy soliciting materials
17 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
3 Jun 22
DEF 14A
Definitive proxy
3 Jun 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
Other
UPLOAD
Letter from SEC
26 Dec 18
CORRESP
Correspondence with SEC
4 Dec 18
UPLOAD
Letter from SEC
19 Nov 18
CORRESP
Correspondence with SEC
11 Oct 18
CORRESP
Correspondence with SEC
5 Oct 18
UPLOAD
Letter from SEC
13 Sep 18
CORRESP
Correspondence with SEC
17 Aug 18
UPLOAD
Letter from SEC
3 Aug 18
CT ORDER
Confidential treatment order
12 Apr 18
UPLOAD
Letter from SEC
19 Oct 17
Ownership
4
Alice Lin-Tsing Yu
29 Mar 24
4
JOHN A PAGANELLI
29 Mar 24
4
Prem A Lachman
29 Mar 24
4
RICHARD C PFENNIGER JR
29 Mar 24
4
RICHARD M KRASNO
29 Mar 24
4
ROGER MD MEDEL
29 Mar 24
4
PHILLIP MD ET AL FROST
18 Mar 24
4
PHILLIP MD ET AL FROST
14 Mar 24
4
PHILLIP MD ET AL FROST
13 Mar 24
4
PHILLIP MD ET AL FROST
12 Mar 24